Investing
Sending You to Google News in 3
Our top personal finance-related articles today. Your wallet will thank you later.
The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) tells a story of increasing concentration. The S&P 500 has become a technology-dominated…
If you own MSTU, you’re making a specific bet: that MicroStrategy’s Bitcoin holdings will move sharply higher in the near…
The YieldMax MSTR Option Income Strategy ETF generates income by selling covered call options on MicroStrategy stock rather than collecting…
The Bitcoin (CRYPTO: BTC) $98K breakout just changed the market structure. Bitcoin broke above $95,000 resistance and briefly touched $98,000…
The artificial intelligence (AI) revolution has sparked a new wave of high-performing investments, including Nvidia (NASDAQ:NVDA), which has become the…
When bond investors chase yield, they often overlook the engine that drives total returns: price appreciation from interest rate movements.…
The iShares MSCI China ETF (NYSEARCA:MCHI) has climbed 45% over the past year, crushing the S&P 500’s 19% gain by…
The Magnificent Seven stocks now represent 35% to 40% of the S&P 500, creating historically high concentration risk. SPDR S&P…
When it comes to claiming Social Security, there are a lot of different opinions out there. Suze Orman, a noted…
Military doctrine is supposed to tell soldiers how to fight, but history shows that some weapons refuse to follow the…
Financial expert Dave Ramsey is known for his ability to cut through the noise surrounding how ordinary, everyday people can…
Markets have a habit of throwing babies out with the bathwater. Dividend stocks like Noble Corporation (NYSE:NE), Booz Allen Hamilton…
When growth stocks dominate headlines and valuations stretch, finding established companies trading at reasonable prices becomes harder. Vanguard Mega Cap…
Shares of Ford Motor Company (NYSE: F) lost 0.51% over the past month after gaining 6.13% the month prior. The…
Dave Ramsey is full of financial advice. And much of it tends to follow a similar pattern: Save money. Avoid…
When Apellis Pharmaceuticals (APLS) secured FDA approval for EMPAVELI in C3 glomerulopathy and IC-MPGN last summer, the stock was trading…
When mega-cap tech stocks trade at valuations that would make even the dot-com era blush, mid-cap value starts looking like…
There’s been a lot of buzz around OpenAI and the secret device(s) it’s been working on behind the scenes with…